Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Emberson

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Clinical Trials (London, England)|February 20, 2008
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent, Frank E Harrell, Marc Buyse, et al.
BMJ (Clinical Research Ed.)|June 3, 2006
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsPatricia M Kearney, Colin Baigent, Jon Godwin, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
Family Practice|September 16, 2004
The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart StudyDebbie A Lawlor, Peter Whincup, Jonathan R Emberson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 10, 2004
Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart StudyJonathan R Emberson, Peter H Whincup, Richard W Morris, et al.
BMJ (Clinical Research Ed.)|March 10, 2015
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive studyClaire L Vale, Larysa H M Rydzewska, Maroeska M Rovers, et al.
Circulation|March 12, 2003
Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart StudyDebbie A Lawlor, Jonathan R Emberson, Shah Ebrahim, et al.
Nephron. Clinical Practice|May 25, 2007
A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spotsMarion M Mafham, Ioana Niculescu-Duvaz, Jeffrey Barron, et al.
BMJ (Clinical Research Ed.)|July 2, 2004
Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurementPeter H Whincup, Julie A Gilg, Jonathan R Emberson, et al.
European Heart Journal|February 28, 2008
Biomarkers of inflammation predict both vascular and non-vascular mortality in older menRobert Clarke, Jonathan R Emberson, Elizabeth Breeze, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Clinical Trials (London, England)|February 20, 2008
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent, Frank E Harrell, Marc Buyse, et al.
BMJ (Clinical Research Ed.)|June 3, 2006
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsPatricia M Kearney, Colin Baigent, Jon Godwin, et al.
Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.
Family Practice|September 16, 2004
The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart StudyDebbie A Lawlor, Peter Whincup, Jonathan R Emberson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 10, 2004
Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart StudyJonathan R Emberson, Peter H Whincup, Richard W Morris, et al.
BMJ (Clinical Research Ed.)|March 10, 2015
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive studyClaire L Vale, Larysa H M Rydzewska, Maroeska M Rovers, et al.
Circulation|March 12, 2003
Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart StudyDebbie A Lawlor, Jonathan R Emberson, Shah Ebrahim, et al.
Nephron. Clinical Practice|May 25, 2007
A practical method of measuring glomerular filtration rate by iohexol clearance using dried capillary blood spotsMarion M Mafham, Ioana Niculescu-Duvaz, Jeffrey Barron, et al.
BMJ (Clinical Research Ed.)|July 2, 2004
Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurementPeter H Whincup, Julie A Gilg, Jonathan R Emberson, et al.
European Heart Journal|February 28, 2008
Biomarkers of inflammation predict both vascular and non-vascular mortality in older menRobert Clarke, Jonathan R Emberson, Elizabeth Breeze, et al.
Pageof 8